Glutaminase inhibitor compound 968 inhibits cell proliferation and sensitizes paclitaxel in ovarian cancer

Objective: Our overall goal was to investigate the anti-tumor activity of the glutaminase 1 (GLS1) Inhibitor compound 968 in ovarian cancer cells. The human ovarian cancer cell lines, HEY, SKOV3 and IGROV-1 were used. Cell proliferation was assessed by MTT assay after treatment with compound 968. Ce...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Am J Transl Res
Главные авторы: Yuan, Lingqin, Sheng, Xiugui, Clark, Leslie H, Zhang, Lu, Guo, Hui, Jones, Hannah M, Willson, Adam K, Gehrig, Paola A, Zhou, Chunxiao, Bae-Jump, Victoria L
Формат: Artigo
Язык:Inglês
Опубликовано: e-Century Publishing Corporation 2016
Предметы:
Original Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5095319/
https://ncbi.nlm.nih.gov/pubmed/27830010
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы